Unmasking Nrf2 as a key driver of treatment resistance in osteosarcoma

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

A deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is reshaping strategies for overcoming treatment resistance.